Med-X, Inc. (MXRX)
Med-X will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$4.00 - $6.00
Shares Offered
1,150,000
Deal Size
$5.75M

Med-X Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20212020
Revenue
1.011.03
Revenue Growth (YoY)
-2.26%-
Cost of Revenue
0.880.87
Gross Profit
0.130.16
Selling, General & Admin
2.151.63
Other Operating Expenses
3.212.07
Operating Expenses
5.363.69
Operating Income
-5.23-3.53
Interest Expense / Income
-00.01
Other Expense / Income
-0.32-
Pretax Income
-4.91-3.54
Net Income
-4.91-3.54
Free Cash Flow
-4.45-3.31
Gross Margin
12.94%15.79%
Operating Margin
-517.47%-341.60%
Profit Margin
-485.68%-342.54%
Free Cash Flow Margin
-440.57%-319.75%
EBITDA
-4.86-3.42
EBITDA Margin
-480.59%-330.68%
Depreciation & Amortization
0.050.11
EBIT
-4.91-3.53
EBIT Margin
-485.84%-341.60%
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).